Raffaele Addeo
Overview
Explore the profile of Raffaele Addeo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fasano M, Pirozzi M, Vitale P, Damiano V, Ronzino G, Farese S, et al.
World J Clin Oncol
. 2024 Dec;
15(12):1468-1480.
PMID: 39720642
Background: Squamous cell carcinoma of the head and neck (SCCHN) accounts for 3% of all malignant tumors in Italy. Immune checkpoint inhibitors combined with chemotherapy is first-line treatment for SCCHN;...
2.
Abate M, Porru M, Campani V, Leonetti C, Nele V, Di Paola R, et al.
J Control Release
. 2024 Nov;
377:458-469.
PMID: 39577464
Glioblastoma (GBM) is a highly aggressive brain cancer with poor clinical outcome. Unfortunately, chemotherapy with temozolomide (TMZ) has a limited efficacy due to resistance mainly attributed to O6-methylguanine methyl transferase...
3.
Grisolia P, Tufano R, Iannarone C, De Falco A, Carlino F, Graziano C, et al.
J Transl Med
. 2024 Oct;
22(1):938.
PMID: 39407254
Background: Recent studies have highlighted the importance of the cell-free DNA (cfDNA) methylation profile in detecting breast cancer (BC) and its different subtypes. We investigated whether plasma cfDNA methylation, using...
4.
Interno V, Melaccio A, Vitale P, Spedaliere R, Buonfantino M, Messina R, et al.
Chin Clin Oncol
. 2024 Sep;
13(5):69.
PMID: 39260430
Background And Objective: The identification of mutation hot spots in the isocitrate dehydrogenase (IDH) genes is one of the most important cancer genome-wide sequencing discoveries with relevant impact in the...
5.
Fasano M, Pirozzi M, De Falco V, Miceli C, Farese S, Zotta A, et al.
Oncol Lett
. 2024 Jul;
28(3):418.
PMID: 39006948
The Stupp regimen remains the standard treatment for newly diagnosed glioblastomas, although the prognosis remains poor. Several temozolomide alternative schedules have been studied, with extended adjuvant treatment (>6 cycles of...
6.
Fasano M, Pirozzi M, Miceli C, Cocule M, Caraglia M, Boccellino M, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000507
Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, with 20% of patients presenting with metastatic disease at diagnosis. TGF-β signaling plays a crucial role in various cellular...
7.
Falco M, Tammaro C, Cossu A, Takeuchi T, Tufano R, Ceccarelli M, et al.
J Transl Med
. 2024 Jul;
22(1):647.
PMID: 38987822
Background: The growing understanding of cancer biology and the establishment of new treatment modalities has not yielded the expected results in terms of survival for Laryngeal Squamous Cell Cancer (LSCC)....
8.
Addeo R, Caraglia F, Fasano M, Spedaliere R, Cocozza E
Oncology
. 2024 Jul;
102(11):1004-1008.
PMID: 38976972
No abstract available.
9.
Bocchetti M, Luce A, Iannarone C, Pasquale L, Falco M, Tammaro C, et al.
J Transl Med
. 2024 Jun;
22(1):582.
PMID: 38902710
Background: Exosomes are nanosized vesicles released from all cells into surrounding biofluids, including cancer cells, and represent a very promising direction in terms of minimally invasive approaches to early disease...
10.
Vitale P, De Falco V, Addeo R
Expert Rev Anticancer Ther
. 2024 May;
24(7):481-484.
PMID: 38733083
No abstract available.